Neonatal Sepsis clinical trials

Explore recruiting neonatal sepsis clinical trials.

Recruiting neonatal sepsis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Neonatal Sepsis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A follow-up trial to assess the persistence of the immune response to the Group B Streptococcus vaccine (GBS‑NN/NN2) after a primary vaccination of healthy pregnant women, and to assess safety, reactogenicity and immunogenicity of the GBS‑NN/NN2 vaccine when administered during the follow-up as a 1 booster dose during a new pregnancy

Denmark

Phase II and Phase III (Integrated) EU CTIS Study details

Antibiotic pharmacokinetics in women with twin pregnancy

Austria

Therapeutic use (Phase IV) EU CTIS Study details

A Randomised, Observer-Blind Trial to Evaluate the Immunogenicity, Safety, and Reactogenicity of a Group B Streptococcus Vaccine (GBS-NN/NN-2) when 1 Dose is Administered Concomitantly with the TDaP Vaccine in Healthy Non-pregnant Women 18 to 49 years of age Compared to when Each Vaccine is Administered Alone

Belgium, Poland

Phase II and Phase III (Integrated) EU CTIS Study details

Metformin for the prolongation of pregnancy in preterm preeclampsia: the PI-NL trial

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Aspirin versus placebo in twin pregnancies for preeclampsia prevention: A multicentre, randomised, double-blind, placebo-controlled trial (ASPRE-T)

Spain, Belgium, Poland, Austria, Czechia, Denmark +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Neonatal Sepsis trials by city

Neonatal Sepsis in Toronto Neonatal Sepsis in Vancouver Neonatal Sepsis in Montreal Neonatal Sepsis in Calgary Neonatal Sepsis in Edmonton Neonatal Sepsis in Ottawa Neonatal Sepsis in Winnipeg Neonatal Sepsis in Quebec City Neonatal Sepsis in Hamilton Neonatal Sepsis in Kitchener Neonatal Sepsis in London Neonatal Sepsis in Halifax Neonatal Sepsis in New York Neonatal Sepsis in Los Angeles Neonatal Sepsis in Chicago Neonatal Sepsis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease